On Hims & Hers Q4 earnings conference call, the company said it may have a “temporary pause in year-over-year margin expansion” due to investments starting in Q4 and continuing through 2026 that are designed to scale new categories, build a larger presence in new markets, and driving greater value to subscribers through partnerships.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- HIMS Earnings: Hims & Hers Health Reports Mixed Financial Results
- Hims & Hers reports Q3 EPS 6c, consensus 10c
- Hims & Hers sees Q4 revenue $605M-$625M, consensus $629.6M
- Hims & Hers sees FY25 revenue $2.335B-$2.355B, consensus $2.34B
- Hims and Hers Health options imply 12.6% move in share price post-earnings